Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 03, 2010 08:30 ET | Source: Inergetics, Inc.

Columbia University Division of Pediatric Oncology Chooses Millennium Biotechnologies' Resurgex Select(R) for Multi-Site Clinical Trial

PARAMUS, N.J., March 3, 2010 (GLOBE NEWSWIRE) -- Millennium Biotechnologies Group Inc. (OTCBB:MBTG), a leader in the development of targeted nutritional products in the Clinical Nutrition Market and...